Tsumura & Co.
OTC: TSMRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Terukazu Kato
- Employees
- 4,138
- Headquarters
- Tokyo, Japan
- IPO year
- 2013
- Market cap
- $1.7B
- Website
- https://www.tsumura.co.jp
Loading TSMRF…
Loading profile data…Frequently asked questions about TSMRF
What does Tsumura & Co. (TSMRF) do?
Tsumura & Co. is a global pharmaceutical company specializing in the production and distribution of various medicinal products. Their core offerings include Kampo extract intermediates and granular Kampo formulations. The company manages the comprehensive process of bringing these traditional remedies to market, from the sourcing, meticulous sel...
Where does TSMRF trade?
Tsumura & Co. (TSMRF) trades on the Other OTC.
What sector is TSMRF in?
Tsumura & Co. (TSMRF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tsumura & Co.?
Terukazu Kato is the chief executive officer of Tsumura & Co. (TSMRF).
Where is Tsumura & Co. headquartered?
Tsumura & Co. is headquartered in Japan.
Does TSMRF pay a dividend?
Yes — Tsumura & Co. (TSMRF) paid a trailing twelve-month dividend of USD 1.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TSMRF go public?
Tsumura & Co. (TSMRF) completed its initial public offering in 2013.